GLOW Blend 50mg Dosage Protocol

1. Preparation and Measurement

GLOW Blend 50mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 25mg/mL. On a U-100 syringe, each unit contains 250mcg.

Preparation

1. Draw 2mL of bacteriostatic water using sterile equipment.
2. Let the liquid run slowly down the inside wall of the vial.
3. Gently swirl until dissolved. Do not shake.
4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in circulated protocols. Frequency: once daily for four weeks.

Vial estimate: One 50mg vial contains approximately 20 documented-size administrations at 2.5mg.

Practical Notes

• The table applies only to this vial prepared with exactly 2mL.
• At 10 units: 250mcg BPC-157, 1.75mg GHK-CU, and 500mcg TB-500.
• Record the amount, date, and preparation used.

3. Supplies Needed

• GLOW Blend 50mg vial.
• 2mL of bacteriostatic water per vial.
• Sterile U-100 syringes.
• Alcohol swabs.
• Sharps container.

4. Storage and Handling

• Keep unopened vials cool, dry, dark, and protected from moisture.
• After preparation, refrigerate at 2-8 degrees C.
• Protect from light and avoid repeated freeze-thaw cycles.
• Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

GLOW combines BPC-157, GHK-CU, and TB-500 in a fixed ratio. The exact three-component blend has not been evaluated in controlled human trials.

Research on individual components cannot establish the combined material's safety, efficacy, interactions, or optimal schedule. The table records a circulated total-mass convention only.

Primary Research and Regulatory References

1. BPC-157 rat Achilles tendon study
2. Copper peptide tissue-remodelling review
3. GHK-Cu gene-expression research
4. Thymosin beta-4 wound-healing research